Infectious Disease · Public Health · 2 h ago
Ugandan providers identify opportunities and barriers for dapivirine PrEP ring use
A qualitative study used six focus groups with 60 government health care providers in rural Uganda to explore views on the dapivirine vaginal ring for adolescent girls and young women. Providers saw potential advantages over pills but also raised concerns about stigma, supply and education.
- Providers viewed the ring as discreet and non-hormonal.
- Stigma, stockouts and education policy were concerns.
- Participants emphasized educating male partners and community members.
Researchers conducted six hybrid focus group discussions with 60 government health care providers in Rakai and Kyotera Districts, Uganda. Participants included 25 nurses, 18 midwives and 17 community health workers; transcripts were analyzed using conventional content analysis. The study explored providers’ perspectives on use of the dapivirine vaginal ring for HIV pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW).
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
BMC Public Health: Health care provider perspectives on the PrEP (dapivirine) ring for adolescent girls and young women in rural Uganda (“ProPrEP”) ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.